Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Clinical trial NCT01802450 · UNKNOWN

Trial details

NCT number: NCT01802450
Sponsor: PETHEMA Foundation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2013-03-01
Primary completion: 2015-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.